A cutting-edge mitochondrial peptide that supports cellular energy and fights oxidative stress, often used by clients experiencing brain fog, fatigue, or signs of early aging
In preclinical models, KLOW provides simultaneous input into cytoprotective growth factor pathways (BPC-157), actin-regulated cell migration (TB-500), melanocortin-mediated anti-inflammatory suppression (KPV), and copper-dependent collagen and antioxidant gene activation (GHK-Cu)
This transparent, non-tiered approach removes cost barriers as your treatment progresses and your dose is adjusted for optimal results
Patients with pre-existing conditions including cardiovascular disease, liver disease, thyroid disorders, kidney disease, or gallbladder disease face particular uncertainty
ADVANTAGES OF LYOPHILIZED: Optimal stability and solubility
Dehydration can reduce the effectiveness of semaglutide and increase the risk of kidney strain, especially if you have any underlying renal concerns